Helen Collins

Helen Collins

Chief Tech/Sci/R&D Officer at ENLIVEN THERAPEUTICS, INC.

Net worth: - $ as of 31/03/2024

61 year
Health Technology
Consumer Services
Health Services

Profile

Helen Collins is the founder of North Bay Cancer Alliance, Inc. She currently holds positions as an Independent Director at Kura Oncology, Inc., Director at IO Biotech, Inc., and Chief Medical Officer at Enliven Therapeutics, Inc. Her former positions include Chief Medical Officer & Executive Vice President at Five Prime Therapeutics, Inc. and President at Redwood Regional Medical Group, Inc. She received her undergraduate degree from Bryn Mawr College in 1984 and her doctorate from The Johns Hopkins University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/05/2023 0 ( -.--% ) - $ 31/03/2024
11/04/2024 0 ( -.--% ) - $ 31/03/2024

Helen Collins active positions

CompaniesPositionStart
KURA ONCOLOGY, INC. Director/Board Member 29/07/2021
ENLIVEN THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 23/02/2023
IO BIOTECH, INC. Director/Board Member 09/11/2023
All active positions of Helen Collins

Former positions of Helen Collins

CompaniesPositionEnd
FIVE PRIME THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 16/04/2021
President 01/01/2009
Founder -
See the detail of Helen Collins's experience

Training of Helen Collins

Bryn Mawr College Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Helen Collins's experience

Connections

81

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
KURA ONCOLOGY, INC.

Health Technology

IO BIOTECH, INC.

Health Technology

Private companies4

Health Technology

Health Services

Commercial Services

Enliven Therapeutics, Inc.

See company connections